Clinical Trial Update: Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis [Phase 2]

View source ↗

Summary

This completed Phase II trial evaluated fluconazole for lymphocutaneous and visceral sporotrichosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sporotrichosis

Drugs mentioned

• Fluconazole (Fluconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Sporotrichosis | Phase 2 | Status: COMPLETED